Posts Tagged 'multidistrict litigation'

Panelists question antidepressant use

During a panel discussion on clinical depression at Marquette University in Wisconsin, some participants speculated that antidepressants might be over-prescribed.

An article about the event in the Marquette Tribune says one of the panel participants was Katherine Sharpe, the author of “Coming of Age on Zoloft.” Sharpe, who was first prescribed Zoloft when she was in college, questions whether the widespread practice of medical professionals automatically prescribing antidepressants harms the emotional development ...

continue reading...

Research may aid treatment of depression

According to a Reuters story, scientists have identified biological markers in the blood that may eventually help doctors match patients to the best type of treatment for depression.

The story says major depression affects around 20 percent of people at some point in their lives, and the World Health Organization predicts it will soon rival heart disease as the health disorder with the highest global disease burden.

But up to now, treatment has ...

continue reading...

Study: Antidepressants raise accident risk

According to a story in the Daily Mail, a study from the University of Taiwan finds that taking common antidepressants increases the risk of automobile accidents.

Researchers found those taking a common group of antidepressants known as selective serotonin reuptake inhibitors were 72 percent more at risk.

This isn’t the first time that a study has identified a safety risk associated with taking SSRI antidepressants. A number of studies have linked SSRI antidepressants ...

continue reading...

Alternatives exist to antidepressants

In a column for the Chicago Daily Herald, Patrick B. Massey, M.D., Ph.D, explores the question of how effective antidepressants are, and what alternatives are available.

Antidepressants are now the most commonly prescribed class of medication in the United States. About 1 in 10 Americans is taking one or more antidepressants – a figure that has doubled over the last 20 years.

Recently published research has indicated that prescription antidepressants work best for ...

continue reading...

Prozac maker going through tough times

An article on investment blog Seeking Alpha highlights some recent problems facing pharmaceutical giant Eli Lilly, which potential investors might want to consider.

According to the blog, test results for a new schizophrenia drug proved disappointing. So much so that the company halted research into the product.

A new treatment for Alzheimer’s proved only partially effective against a mild form of the disease, and useless in most cases. A recent study also revealed ...

continue reading...

Drug maker apologizes for birth defects

The German manufacturer of the drug thalidomide, which has been blamed for about 10,000 birth defects, has issued its first apology to victims in 50 years, the Pittsburgh Post Gazette reports.

Harald Stock, chief executive of the Grünenthal Group, made the apology during a speech at the unveiling of a thalidomide memorial, a bronze statue of a limbless child.

Addressing the victims and their families, he said “…we have been silent, and we ...

continue reading...
Page 5 of 16 «...34567...»